Following a 75% decline over last year, recent gains may please Nektar Therapeutics (NASDAQ:NKTR) institutional owners
Key Insights Given the large stake in the stock by institutions, Nektar Therapeutics' stock price might be vulnerable...
Stay updated with breaking news from Hare Registry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key Insights Given the large stake in the stock by institutions, Nektar Therapeutics' stock price might be vulnerable...
Key Insights Allbirds' significant retail investors ownership suggests that the key decisions are influenced by...
Key Insights Institutions' substantial holdings in Uber Technologies implies that they have significant influence over...
Key Insights Significantly high institutional ownership implies HomeStreet's stock price is sensitive to their trading...
Key Insights Institutions' substantial holdings in Metcash implies that they have significant influence over the...